Published • loading... • Updated
Insider Selling: Kymera Therapeutics (NASDAQ:KYMR) CEO Sells $3,414,000.00 in Stock
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Insider Selling: Kymera Therapeutics (NASDAQ:KYMR) CEO Sells $3,414,000.00 in Stock
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) CEO Nello Mainolfi sold 30,000 shares of Kymera Therapeutics stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $113.80, for a total transaction of $3,414,000.00. Following the transaction, the chief executive officer directly owned 666,568 shares in […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
